Home » Insilicos, GeneBio, Geneva Bioinformatics, Current Science Group, Bruker BioSciences, ABI, MDS Sciex, Phenomenome, Lynx

Insilicos, GeneBio, Geneva Bioinformatics, Current Science Group, Bruker BioSciences, ABI, MDS Sciex, Phenomenome, Lynx

Mar 04, 2005
Premium

Insilicos wins $400K Proteomics Software Development Grant from NHLBI

Insilicos announced last week that it has been awarded a two-year, $400,000 grant from the National Heart, Lung, and Blood Institute to develop a general-purpose proteomics software suite.

The Seattle-based life science software developer said that it planned to use the funding to “improve and extend” the XML-based Trans-Proteomic Pipeline software, which is being developed by Insilicos’ collaborator, the Instutute for Systems Biology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

This Week in PNAS

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

'Lifestyle Zone'

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

What's Popular?

In Proteomics & Protein Research

  1. FDA, NCI Memorandum Indicates Growing Interest in Proteogenomics as Clinical Approach

    Premium

  2. Late-Onset Preeclampsia Markers Proposed From Proteomic Study

  3. Waters Q2 Revenues Grow 4 Percent

  4. PNNL Team Pushing Sensitivity Limits of Targeted Proteomics

    Premium

  5. WUSTL Team Develops Blood-Based Test for Brain Amyloidosis

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.